Overused Dexamethasone Induced Exogenous Cushing’s Syndrome, Diabetes Mellitus, and Pneumonia

Authors

  • Putu Gede Indra Dananjaya Regional General Hospital Klungkung, Indonesia
  • Ni Made Putri Purnama Dewi Internal Medicine Medical Staff of Klungkung Regional General Hospital

DOI:

https://doi.org/10.38035/ijphs.v2i3.604

Keywords:

Cushing’s Syndrome, Diabetes Mellitus, Pneumonia, Dexamethasone, Melena

Abstract

Cushing's syndrome is a collection of clinical symptoms resulting from excessive exposure to glucocorticoid hormones. The cause of Cushing's syndrome can be endogenous or exogenous factors. Exogenous factors caused by long-term use of corticosteroid drugs. Clinical manifestations that can be found include weight gain, often accompanied by a moon face, central obesity, fat deposits in the dorsocervical and supraclavicular areas, proximal muscle weakness, fatigue, leg edema, easy bruising, thinning skin, and striae. We report the case of a patient with exogenous Cushing's syndrome, diabetes mellitus, and pneumonia induced by excessive dexamethasone consumption accompanied by melena. Treatment should be carried out comprehensively by paying attention to the underlying disease. Discontinuation of glucocorticoids is the main treatment and needs to be done gradually. In this case, a stress dose of glucocorticoid was not given because he was experiencing gastrointestinal bleeding.

References

Ahmed, S. et al. 2021. “Topical Corticosteroid-induced Iatrogenic Cushing Syndrome in an Infant: A Case Report With Literature View.” https://doi.org/10.1016/j.amsu.2021.102978

Alwi, I, A. et al. 2019. Penatalaksanaan di Bidang Ilmu Penyakit Dalam Panduan Praktik Klinis. Jakarta: PIP Interna.

Chaudhry HS, Singh G. Cushing Syndrome. 2024. Cushing Syndrome : StatPearls. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470218

Dhruv Zaveri, Miral Thakkar, Pankti Solanki, Riki Patel, Jay Rane. (2022). Dexamethasone Induced Cushing's syndrome: A Case Report, Glob Acad J Pharm Drug Res; Vol-4, Iss-3 pp- 73-75.

Geetha, K. et al. 2024. Prednisolone-Induced Cushing’s Syndrome : A Case Report. World Journal of Advanced Research and Review. 21(01), 2471-2473. https://doi.org/10.30574/wjarr.2024.21.1.0056

Pivonello, et al. 2010. Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome. Neuroendocrinology Vol. 92(suppl 1), hal 77-81. DOI: 10.1159/000314319

Ratna, S. et al. 2022. Steroid Induced Cushing’s Syndrome in an Asthmatic Patient: A Case Report. Modern Medicine Journal. https://doi.org/10.31689/rmm.2023.30.3.247

Reincke, M. dan Fleserlu, M. 2023. Cushing Syndrome A Review. Clinical Review & Education. American Medical Association. JAMA. 2023;330(2):170-181. doi:10.1001/jama.2023.11305

Sharma, et al. 2015. Cushing’s Syndrome: Epidemiology and Developments In Disease Management. Dovepress. Hal 281-293. https://doi.org/10.2147/CLEP.S44336

Soelistijo, S.A, et al. 2020. Sindroma Cushing Eksogen: “Kapan Penggunaan Dosis Stres Glukokortikoid Bermanfaat?”. Jurnal Penyakit Dalam Indonesia. Vol. , No. 3. Hal 181-185.

Soelistijo, S.A., et al. 2021. Pedoman Pengelolaan dan Pencegahan Diabetes Mellitus Tipe 2 Dewasa di Indonesia. PB PERKENI

Tarigan, T.J.E. 2014. Buku Ajar Ilmu Penyakit Dalam Jilid II Edisi VI: Sindrom Cushing dan Penyakit Cushing. Jakarta: Interna Publishing. Hal: 2478-2483

Published

2024-07-20